- Molina’s adjusted EPS for Q4 2025 was $5.05, missing the estimate of $5.84, but higher than the previous year’s EPS of $4.38.
- The company’s revenue increased by 16% year-over-year, reaching $10.50 billion, surpassing the estimated $10.3 billion.
- The medical care ratio rose to 90.2%, compared to 89.1% from the previous year.
- Analysts have issued 5 buy ratings, 10 hold ratings, and 1 sell rating for Molina.
Molina Healthcare on Smartkarma
Analyst coverage on Molina Healthcare on the independent investment research platform Smartkarma is providing valuable insights for investors. Value Investors Club‘s report on Molina Healthcare highlights the company’s strong position in the Managed Medicaid market, where its efficient business model minimizes risks and maximizes opportunities. This report, originally published 3 months ago, underscores Molina’s advantage in bidding for state programs and its success in managing Medicaid services for low-income individuals.
Furthermore, Baptista Research‘s analysis delves into Molina Healthcare‘s recent performance in the third quarter of 2024. Despite facing challenges such as upward pressure on medical costs, Molina Healthcare maintained a solid financial standing with adjusted earnings per share meeting expectations and a strong adjusted pre-tax margin. This report emphasizes key drivers impacting Molina Healthcare‘s performance beyond 2025, providing investors with essential information to assess the company’s future prospects.
A look at Molina Healthcare Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 1 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores analysis, Molina Healthcare shows a promising long-term outlook. With a strong emphasis on growth and resilience, the company has been rated highly in these aspects, scoring 4 out of 5 for both factors. This indicates that Molina Healthcare is well-positioned to expand its operations and navigate through challenges effectively in the coming years.
While the company scores lower on the dividend factor at 1 out of 5, its overall value and momentum stand at 3 out of 5. This suggests that Molina Healthcare may offer potential for value investors and has moderate momentum in the market. With a focus on providing health care services to low-income families and individuals through various health plans and clinics, Molina Healthcare Inc. continues to play a vital role in the managed care sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
